Case Study: Bioforum (data-focused CRO) achieves faster, more reliable clinical trials with Medidata Solutions

Bioforum and Medidata Trusted Long-term Partners that Sponsors can Depend on

PolyPid, a Phase 3 biopharma developing D‑PLEX100 to prevent surgical site infections using its PLEX controlled‑release technology, faced the challenge of running a complex, multi‑national, multi‑center trial while ensuring GCP‑compliant design, execution, and uncompromised data accuracy and integrity. They needed regulator‑accepted, trusted partners with experience in Phase 3 studies and advanced data strategies.

PolyPid teamed with Bioforum, a data‑focused CRO, and Medidata, the leading clinical‑research platform. Using Medidata’s unified suite (Rave EDC, Coder, RTSM, Imaging, etc.), Bioforum managed complex study requirements without custom programming, delivered real‑time data visibility, protected data integrity, and accelerated timelines. The long‑standing partnership (nearly a decade and ~30 joint projects) enabled streamlined, regulatory‑compliant data management that supported efficient execution of the Phase 3 program.

Bioforum

Amir Malka

CEO and Co-Founder